Venture Management

AIQ Solutions, Inc. specializes in the development of medical devices and software solutions aimed at the quantitative assessment of lesions related to complex diseases, primarily cancer. The company's clinical decision support platform analyzes medical imaging data to identify and quantify all lesions in cancer patients, tracking changes post-treatment. AIQ Solutions offers innovative products such as quantitative total bone imaging (QTBI), which provides insights into metastatic bone disease, and quantitative total marrow imaging (QTMI), which assesses disease heterogeneity and treatment response in bone marrow. Founded in 2015 and based in Madison, Wisconsin, the company emerged from the University of Wisconsin Translational Imaging Research Program, with its founders possessing extensive experience in drug development and clinical trials. AIQ Solutions has received FDA 510(k) clearance for its QTxI platform, reinforcing its commitment to enhancing patient management and outcomes in oncology. Its products serve oncologists, radiologists, nuclear medicine physicians, and pharmaceutical companies.

HealthMyne, Inc. is a healthcare informatics company based in Madison, Wisconsin, established in 2013. It specializes in providing innovative imaging solutions and analytics primarily for cancer care providers. The company's technology enhances clinical decision-making by offering real-time, evidence-based imaging insights that facilitate improved patient care while also reducing delivery costs. HealthMyne's platform includes features such as tumor image manipulation, automatic tumor staging, specialized reporting, and management of incidental findings, all aimed at streamlining clinical workflows. By integrating electronic health records and image repositories, HealthMyne supports physicians in diagnosing and treating patients more effectively, ultimately enhancing clinical collaboration and quality assurance in patient management.

Swallow Solutions, LLC is a company based in Madison, Wisconsin, dedicated to addressing swallowing disorders, also known as dysphagia, in the United States. Established in 2004, the company specializes in therapeutic devices designed for the diagnosis and treatment of swallowing difficulties, along with nutritional food products tailored to the specific needs of patients based on their condition. One of its primary offerings is SwallowSTRONG, which includes a custom-molded mouthpiece and accompanying software that aids speech language pathologists in implementing evidence-based therapy to strengthen the tongue. Additionally, the SwallowSTRONG Management System is a cloud-based platform that allows clinicians to monitor patient progress remotely, adjust therapy parameters as needed, and access therapy data for analysis and reporting. Through these innovative solutions, Swallow Solutions aims to enhance the health and well-being of individuals with dysphagia.

FluGen, Inc. is a biopharmaceutical company focused on the prevention and treatment of influenza and other respiratory pathogens. Founded in 2007 and based in Madison, Wisconsin, FluGen develops vaccines to combat seasonal and pandemic influenza. Its primary product, RedeeFlu, is a nasal spray vaccine designed to protect against influenza, utilizing a live, single replication virus that has a portion of the M2 segment deleted. This innovative approach allows for effective prevention of influenza and supports healthcare professionals in controlling potential pandemics. The company is actively engaged in clinical-stage vaccine development to address both seasonal influenza and emerging respiratory threats.

Invenra Inc. is a biotechnology company based in Madison, Wisconsin, founded in 2011. The company specializes in discovering and developing biologics, particularly antibodies and their derivatives. Invenra employs a unique drug discovery platform that integrates cell-free expression technology with extreme miniaturization, allowing for the screening of a vast number of full-length antibodies in phenotypic assays. This innovative approach enables the identification and optimization of human multi-specific antibodies for therapeutic applications, including treatments for cancer, Alzheimer's disease, and diabetes. Invenra's team consists of experienced scientists with expertise in genomics, biochemistry, and bioengineering, blending advanced research with practical applications in the development of new biologic drugs.

NeuWave Medical, founded in 2004 and headquartered in Madison, Wisconsin, specializes in the development of energy-based minimally invasive medical devices designed to treat various serious medical conditions. The company's founders, both engineers and physician-scientists, leverage their expertise to identify clinical needs and create effective solutions that prioritize safety and efficacy. NeuWave Medical aims to produce high-quality devices that are preferred by leading physicians and medical centers globally.

Swallow Solutions, LLC is a company based in Madison, Wisconsin, dedicated to addressing swallowing disorders, also known as dysphagia, in the United States. Established in 2004, the company specializes in therapeutic devices designed for the diagnosis and treatment of swallowing difficulties, along with nutritional food products tailored to the specific needs of patients based on their condition. One of its primary offerings is SwallowSTRONG, which includes a custom-molded mouthpiece and accompanying software that aids speech language pathologists in implementing evidence-based therapy to strengthen the tongue. Additionally, the SwallowSTRONG Management System is a cloud-based platform that allows clinicians to monitor patient progress remotely, adjust therapy parameters as needed, and access therapy data for analysis and reporting. Through these innovative solutions, Swallow Solutions aims to enhance the health and well-being of individuals with dysphagia.

Silatronix, Inc. specializes in the development of organosilicon (OS) compounds and formulations for use in energy storage devices, particularly in rechargeable and non-rechargeable lithium-ion batteries. Founded in 2007 and based in Madison, Wisconsin, the company focuses on creating patented materials that enhance battery performance by extending cell life, increasing capacity, and allowing higher charge voltages. Silatronix's technology combines expertise in organosilicon compounds and nanostructured electrodes, making its products suitable for a variety of applications, including portable electronics, electric vehicles, and utility-scale energy storage. The company's innovations support advancements in battery technology, contributing to more efficient and effective energy solutions.

FluGen, Inc. is a biopharmaceutical company focused on the prevention and treatment of influenza and other respiratory pathogens. Founded in 2007 and based in Madison, Wisconsin, FluGen develops vaccines to combat seasonal and pandemic influenza. Its primary product, RedeeFlu, is a nasal spray vaccine designed to protect against influenza, utilizing a live, single replication virus that has a portion of the M2 segment deleted. This innovative approach allows for effective prevention of influenza and supports healthcare professionals in controlling potential pandemics. The company is actively engaged in clinical-stage vaccine development to address both seasonal influenza and emerging respiratory threats.

Swallow Solutions, LLC is a company based in Madison, Wisconsin, dedicated to addressing swallowing disorders, also known as dysphagia, in the United States. Established in 2004, the company specializes in therapeutic devices designed for the diagnosis and treatment of swallowing difficulties, along with nutritional food products tailored to the specific needs of patients based on their condition. One of its primary offerings is SwallowSTRONG, which includes a custom-molded mouthpiece and accompanying software that aids speech language pathologists in implementing evidence-based therapy to strengthen the tongue. Additionally, the SwallowSTRONG Management System is a cloud-based platform that allows clinicians to monitor patient progress remotely, adjust therapy parameters as needed, and access therapy data for analysis and reporting. Through these innovative solutions, Swallow Solutions aims to enhance the health and well-being of individuals with dysphagia.

Silatronix, Inc. specializes in the development of organosilicon (OS) compounds and formulations for use in energy storage devices, particularly in rechargeable and non-rechargeable lithium-ion batteries. Founded in 2007 and based in Madison, Wisconsin, the company focuses on creating patented materials that enhance battery performance by extending cell life, increasing capacity, and allowing higher charge voltages. Silatronix's technology combines expertise in organosilicon compounds and nanostructured electrodes, making its products suitable for a variety of applications, including portable electronics, electric vehicles, and utility-scale energy storage. The company's innovations support advancements in battery technology, contributing to more efficient and effective energy solutions.

Swallow Solutions, LLC is a company based in Madison, Wisconsin, dedicated to addressing swallowing disorders, also known as dysphagia, in the United States. Established in 2004, the company specializes in therapeutic devices designed for the diagnosis and treatment of swallowing difficulties, along with nutritional food products tailored to the specific needs of patients based on their condition. One of its primary offerings is SwallowSTRONG, which includes a custom-molded mouthpiece and accompanying software that aids speech language pathologists in implementing evidence-based therapy to strengthen the tongue. Additionally, the SwallowSTRONG Management System is a cloud-based platform that allows clinicians to monitor patient progress remotely, adjust therapy parameters as needed, and access therapy data for analysis and reporting. Through these innovative solutions, Swallow Solutions aims to enhance the health and well-being of individuals with dysphagia.

TermSync is an accounts receivable automation platform based in Madison, Wisconsin. The company specializes in managing payment term relationships, currently overseeing over 2,000 such relationships between clients and their customers, with a notable performance of over 99% of payments made on or before the due date. TermSync's offerings include a range of receivable software solutions, featuring services like payment plans, payment options, payment assurance, early pay discounts, and a streamlined credit application process. These tools aim to enhance efficiency in managing receivables and improving cash flow for businesses.